Arvinas, Inc.

NASDAQ:ARVN

Biotechnology

Healthcare
$6.77 -1.30%

-$0.10 today

Market cap
$443.01M
Beta
1.75
P/E (TTM)
-2.2
EPS (TTM)
-$3.46
52W Low $6.06High $14.51

Volume 1.09M

Average 0.89M

Balance Sheet

Inspect the capital base behind the business.

Assets

$717.90M

FY 2025 · Annual

-34.2% YoY

Liabilities

$284.10M

FY 2025 · Annual

-46.4% YoY

Equity

$433.80M

FY 2025 · Annual

-22.8% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents108.3M81.3M311.7M100.5M142.9M
Short-term Investments1.39B1.12B949.3M938.9M542.5M
Net Receivables25.7M8M7.2M13.7M6.4M
Inventory00000
Other Current Assets4.5M26.9M12M14.2M8.9M
Total Current Assets1.55B1.24B1.28B1.07B700.7M
Property, Plant & Equipment (Net)16.6M17.8M14M16M13.4M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets12.5M10.8M10.4M8.1M3.8M
Total Non-current Assets29.1M28.6M24.4M24.1M17.2M
Total Assets1.58B1.27B1.3B1.09B717.9M
Account Payables31.3M5.7M17.8M13.4M24.4M
Short-term Debt00000
Tax Payables010.3M700K3.2M0
Deferred Revenue206.2M218.6M163M156.2M71.3M
Other Current Liabilities12.4M18.7M48M22.4M17.5M
Total Current Liabilities261.7M295.1M257.1M229.8M142.5M
Long-term Debt1M1M800K600K400K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)534.3M405.1M386.2M292M134.3M
Other Non-current Liabilities0000100K
Total Non-current Liabilities538.2M408.8M387.5M299.9M141.6M
Total Liabilities799.9M703.9M644.6M529.7M284.1M
Common Stock0100K100K100K0
Retained Earnings(682.9M)(965.4M)(1.33B)(1.53B)(1.61B)
Accumulated OCI(4.6M)(19.2M)(3.1M)1M1.2M
Other Stockholders Equity00000
Minority Interest00000
Total Equity781.7M564.9M660M561.7M433.8M
Total Debt5M5.5M3.2M9.7M8.9M
Net Debt(103.3M)(75.8M)(308.5M)(90.8M)(134M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$87.3M
Short-term Investments$527.6M
Receivables$6.4M
Other Current$9.4M
Total Current Assets$630.7M
PP&E (Net)$13.3M
Other Non-current$3.5M
Total Non-current Assets$16.8M
Total Assets$647.5M

Analysis

Selected assets total $647.5M for Latest. The largest visible component is Short-term Investments at $527.6M, about 81.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 9, 2026
10-QQuarterly reportNov 3, 2026
S-3S-3 filingNov 3, 2026
8-KCurrent reportNov 3, 2026
S-8S-8 filingSep 28, 2026

How much cash does ARVN have?

Arvinas, Inc. (ARVN) reported $142.90M in cash and equivalents in fiscal 2025.

How much debt does ARVN carry?

Arvinas, Inc. (ARVN) reported $8.90M of total debt, with net debt of -$134.00M.